Annals of Thoracic Medicine Official publication of the Saudi Thoracic Society, affiliated to King Saud University
Search Ahead of print Current Issue Archives Instructions Subscribe e-Alerts Login 
Home Email this article link Print this article Bookmark this page Decrease font size Default font size Increase font size

Year : 2007  |  Volume : 2  |  Issue : 2  |  Page : 45-46
Classification of asthma according to revised 2006 GINA: Evolution from severity to control

Allergy and Clinical Immunology, Department of Internal Medicine - Faculty of Medicine - King Abdulaziz University, General Secretary of the Saudi Society of Internal Medicine, Saudi Arabia

Date of Submission20-Feb-2007
Date of Acceptance05-Mar-2007

Correspondence Address:
Emad A Koshak
Allergy and Clinical Immunology, Department of Internal Medicine - Faculty of Medicine - King Abdulaziz University, Secretary General of the Saudi Society of Internal Medicine
Saudi Arabia
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/1817-1737.32228

Rights and Permissions

How to cite this article:
Koshak EA. Classification of asthma according to revised 2006 GINA: Evolution from severity to control. Ann Thorac Med 2007;2:45-6

How to cite this URL:
Koshak EA. Classification of asthma according to revised 2006 GINA: Evolution from severity to control. Ann Thorac Med [serial online] 2007 [cited 2023 Feb 7];2:45-6. Available from:

Asthma has grown to be one of the leading chronic illnesses throughout the world, affecting more than 300 million people of all ages. When uncontrolled, asthma can place rigorous restrictions on everyday life. On the other hand, there are so many options of therapeutic modalities including both old and more advanced medications for the control of asthma symptoms.

In order to effectively combat any chronic illness, one needs to develop and follow strategic guidelines that optimize its diagnosis, management and control. These guidelines are continuously revised and updazted according to the opinions of experts, knowledge of current scientific research, the appearance of more effective drugs or the inappropriateness in the application of a particular guideline on patients in real life.

In 1993, the Global Initiative for Asthma (GINA) was formed. Its goals and objectives were described in a 1995 NHLBI/WHO Workshop Report, Global Strategy for Asthma Management and Prevention (GSAMP). This report was revised in 2002 and its companion documents have been widely distributed and translated into many languages.

As the GINA committees expanded their work, the report was updated annually. The first update was posted in October 2003, a second in October 2004 and a third in October 2005, each including the impact of publications from January through December of the previous year.

All previous GINA reports recommended the categorization of asthmatics according to their clinical severity into four levels: Intermittent, mild persistent [Table - 1]. Accordingly, this has helped asthma care providers to stratify patients to gain a clear stepwise approach of treatment options.

In January 2004, the GINA executive committee recommended that the report be revised to emphasize asthma management based on clinical control rather than classification of the patient by severity. This important paradigm shift for asthma care reflects the progress that has been made in understanding the impact of the disease and the pharmacologic care of patients.

The entire, newly revised document of November 2006 emphasizes asthma control. There is now good evidence that the clinical manifestations of asthma-symptoms, sleep disturbances, limitations of daily activity, impairment of lung function and use of rescue medications-can be controlled with appropriate treatment.

The document now recommends a classification of asthma by level of control: Controlled, partly controlled or uncontrolled [Table - 2]. This reflects an understanding that asthma severity involves not only the severity of the underlying disease but also its responsiveness to treatment and that severity is not an unvarying feature of an individual patient's asthma but may change over months or years.

Asthma control may be defined in a variety of ways. In general, the term "control" may indicate disease prevention or even cure. However, in asthma, where neither of these are realistic options at present, it refers to control of the manifestations of the disease.

Asthma control means that patients should experience no or minimal symptoms (including at night), have no limitations on their activities (including exercise), have no (or minimal) requirement for rescue medications, have near normal lung function and experience only very infrequent exacerbations [Table - 1],[Table - 2].

Some asthma experts are not yet comfortable with the concept of allowing daytime symptoms twice a week or with the need for reliever rescue treatment twice a week. Additionally, classification of asthma based on severity, according to previous guidelines, is now reserved and recommended only for research purposes.

The role of the healthcare professional is to establish each patient's current level of control and then adjust treatment to gain and maintain control. The new document encourages channeling asthmatics into one of five, rather than four, treatment steps based on the control level, with somewhat extra flexibility and more pharmacological options than before.

This classification based on control level is by far more practical, easier to follow, includes more clinically relevant issues and implies more appropriate decisions on the choice of treatment in a given patient with asthma. In addition, telling the patient that your asthma is controlled or not controlled is more informative than intermittent or persistent asthma, especially when such words are translated into patient's own language.

According to the recent GINA document, many attempts have been made to classify asthma according to etiology, particularly with regard to environmental sensitizing agents (allergic asthma). However, such a classification is limited by the existence of patients in whom no environmental cause can be identified (non allergic asthma). Despite this, an effort to identify allergic asthma should be part of the initial assessment to enable, in some uncontrolled patients, the use of avoidance strategies, allergen-specific immunotherapy and anti-IgE therapy.

In spite of courageous efforts to improve asthma care over the past decade, a preponderance of patients have not benefited from advances in asthma management and many lack even the rudiments of care. A challenge for the next several years is to work with asthma specialists, primary healthcare providers and public health officials in each country to design, implement and evaluate asthma care programs to meet local needs.

Although many doctors dealing with asthma have some skepticism about previous or recent GINA guidelines, nevertheless it is a step forward in winning the fight against asthma.[1]

   References Top

1.Global Initiative for Asthma (GINA), National Heart, Lung and Blood Institute (NHLBI). Global strategy for asthma management and prevention. Global Initiative for Asthma (GINA), National Heart, Lung and Blood Institute (NHLBI): Bethesda (MD); 2006. p. 339. Available from:  Back to cited text no. 1    


  [Table - 1], [Table - 2]

This article has been cited by
1 Investigation of the optic disc and retinal microvasculature by optical coherence tomography angiography in children with asthma
Abdulkerim Karaaslan, BengiEce Kurtul, AyseIdil Cakmak, Cigdem El
Taiwan Journal of Ophthalmology. 2023; 0(0): 0
[Pubmed] | [DOI]
2 Burden of childhood and adolescence asthma in Nigeria: Disability adjusted life years
Maduka D. Ughasoro, Joy N. Eze, Tagbo Oguonu, Emmanuel Obinna Onwujekwe
Paediatric Respiratory Reviews. 2021;
[Pubmed] | [DOI]
3 Severe asthma and eligibility for biologics in a Brazilian cohort
Luane Marques Mello, Karynna P. Viana, Felipe Moraes dos Santos, Luciana T. M. Saturnino, Michelle L. Kormann, Evelyn Lazaridis, Cinthia D. Torreão, Claudia R. Soares, Gabriela A. Abreu, Valmar Bião de Lima, Gabriela P. Pinheiro, Aline Lima-Matos, Eduardo Vieira Ponte, Divya Mohan, John H. Riley, Alvaro A. Cruz
Journal of Asthma. 2021; 58(7): 958
[Pubmed] | [DOI]
4 Unraveling racial disparities in asthma emergency department visits using electronic healthcare records and machine learning
Adeboye A. Adejare, Yadu Gautam, Juliana Madzia, Tesfaye B. Mersha
Journal of Asthma. 2020; : 1
[Pubmed] | [DOI]
5 Efficacy of omalizumab in children, adolescents, and adults with severe allergic asthma: a systematic review, meta-analysis, and call for new trials using current guidelines for assessment of severe asthma
Daniel P. Henriksen, Uffe Bodtger, Kirsten Sidenius, Niels Maltbaek, Lars Pedersen, Hanne Madsen, Ehm A. Andersson, Ole Norgaard, Louise K. Madsen, Bo L. Chawes
Allergy, Asthma & Clinical Immunology. 2020; 16(1)
[Pubmed] | [DOI]
6 A review: quality of life of patients with allergic rhinitis receiving various treatment
Denis S. Tyufilin, Ivan A. Deev, Olga S. Kobyakova, Ekaterina K. Tagina, Evgeny S. Kulikov
Annals of the Russian academy of medical sciences. 2020; 75(2): 106
[Pubmed] | [DOI]
7 Subcutaneous allergen immunotherapy for asthma: A randomized, double-blind, placebo-controlled study with a standardized Blomia tropicalis vaccine
Raúl Lázaro Castro-Almarales, Mercedes Ronquillo-Díaz, Mirta Álvarez-Castelló, José Rodríguez-Canosa, Mayda González-León, Irene Enríquez-Domínguez, Bárbara Ivonne Navarro-Viltre, Maytee Mateo-Morejón, Yunia Oliva-Díaz, Wendy Ramírez-González, Linda Cox, Alexis Labrada-Rosado
World Allergy Organization Journal. 2020; 13(4): 100098
[Pubmed] | [DOI]
8 Hypersegmented airway neutrophils and its association with reduced lung function in adults with obstructive airway disease: an exploratory study
Ravi Lokwani, Peter A B Wark, Katherine J Baines, Daniel Barker, Jodie L Simpson
BMJ Open. 2019; 9(1): e024330
[Pubmed] | [DOI]
9 Serum level of stem cell factor and its soluble receptor in aspirin-exacerbated respiratory disease
Rasoul Nasiri Kalmarzi, Aida Foroutan, Mohammad Abdi, Pedram Ataee, Ali Jalili, Erfan Babaei, Hajar Kashefi, Shilan Mohamadi, Naseh Sigari, Wesam Kooti
Immunotherapy. 2019; 11(15): 1283
[Pubmed] | [DOI]
10 Global Initiative for Asthma 2016–derived asthma control with fluticasone propionate and salmeterol
Eric D. Bateman, William Busse, Søren E. Pedersen, Jean Bousquet, Shaoguang Huang, Xin Zhou, Nadeem Gul, Sally Hollis, Michael Gibbs
Annals of Allergy, Asthma & Immunology. 2019; 123(1): 57
[Pubmed] | [DOI]
11 Impact of Secretory Immunoglobulin A Level on Dental Caries Experience in Asthmatic Children
Abla Arafa, Salwa AlDahlawi, Adel Hussien
International Journal of Clinical Pediatric Dentistry. 2019; 12(5): 414
[Pubmed] | [DOI]
12 Sputum high mobility group box-1 in asthmatic children: a noninvasive sensitive biomarker reflecting disease status
Caterina Cuppari,Sara Manti,Valeria Chirico,Rosangela Caruso,Vincenzo Salpietro,Valentina Giacchi,Francesca Laganà,Teresa Arrigo,Carmelo Salpietro,Salvatore Leonardi
Annals of Allergy, Asthma & Immunology. 2015; 115(2): 103
[Pubmed] | [DOI]
13 Sublingual immunotherapy in mite-sensitized children with atopic dermatitis: a randomized, open, parallel-group study
Valerio Di Rienzo,Gianni Cadario,Teresa Grieco,Antonia G. Galluccio,Carlo Caffarelli,Giuseppe Liotta,Silvia Pecora,Samuele E. Burastero
Annals of Allergy, Asthma & Immunology. 2014;
[Pubmed] | [DOI]
14 The adjuvant effect induced by di-(2-ethylhexyl) phthalate (DEHP) is mediated through oxidative stress in a mouse model of asthma
Huihui You,Shaohui Chen,Lin Mao,Bing Li,Ye Yuan,Rui Li,Xu Yang
Food and Chemical Toxicology. 2014;
[Pubmed] | [DOI]
15 Voriconazole and Posaconazole Improve Asthma Severity in Allergic Bronchopulmonary Aspergillosis and Severe Asthma with Fungal Sensitization
Livingstone Chishimba,Robert M Niven,John Cooley,David W Denning
Journal of Asthma. 2012; 49(4): 423
[Pubmed] | [DOI]
16 Pharmacogenetics of uncontrolled asthma
E S Kulikov, L M Ogorodova, M B Freidin, I A Deev, A A Rudko, P A Selivanova
Russian Journal of Allergy. 2012; 9(6): 6
[Pubmed] | [DOI]
17 Analysis of polymorphisms in T H2-associated genes in Russian patients with atopic bronchial asthma
Dmitrieva-Zdorova, E.V. and Voronko, O.E. and Latysheva, E.A. and Storozhakov, G.I. and Archakov, A.I.
Journal of Investigational Allergology and Clinical Immunology. 2012; 22(2): 126-132
18 The Saudi initiative for asthma - 2012 update: Guidelines for the diagnosis and management of asthma in adults and children
Al-Moamary, M.S. and Alhaider, S.A. and Al-Hajjaj, M.S. and Al-Ghobain, M.O. and Idrees, M.M. and Zeitouni, M.O. and Al-Harbi, A.S. and Al Dabbagh, M.M. and Al-Matar, H. and Alorainy, H.S.
Annals of Thoracic Medicine. 2012; 7(4): 175-204
19 Voriconazole and posaconazole improve asthma severity in allergic bronchopulmonary aspergillosis and severe asthma with fungal sensitization
Chishimba, L. and Niven, R.M. and Cooley, J. and Denning, D.W.
Journal of Asthma. 2012; 49(4): 423-433
20 Utilization and responsiveness of the asthma control test (ACT) at the initiation of therapy for patients with asthma: A randomized controlled trial
Al Moamary, M.S. and Al-Kordi, A.G. and Al Ghobain, M.O. and Tamim, H.M.
BMC Pulmonary Medicine. 2012; 12(14)
21 Investigation into the use of complementary and alternative medicine and affecting factors in Turkish asthmatic patients
Tokem, Y. and Aytemur, Z.A. and Yildirim, Y. and Fadiloglu, C.
Journal of Clinical Nursing. 2012; 21(5-6): 698-707
22 CARD15 and TLR4 polymorphisms in atopic bronchial asthma
Voronko, O.E. and Dmitrieva-Zdorova, E.V. and Latysheva, E.A. and Aksenova, M.G. and Storozhakov, G.I. and Bodoev, N.V. and Archakov, A.I.
Molecular Biology. 2011; 45(5): 766-773
23 Effect of age on asthma control: results from the National Asthma Survey
Neetu Talreja,Alan P. Baptist
Annals of Allergy, Asthma & Immunology. 2011; 106(1): 24
[Pubmed] | [DOI]
24 Effect of age on asthma control: Results from the National Asthma Survey
Talreja, N., Baptist, A.P.
Annals of Allergy, Asthma and Immunology. 2011; 106(1): 24-29
25 Asthma Education for Older Adults: Results from the National Asthma Survey
Alan P. Baptist, Neetu Talreja, Noreen M. Clark
Journal of Asthma. 2011; 48(2): 133
[VIEW] | [DOI]
26 Investigation into the use of complementary and alternative medicine and affecting factors in Turkish asthmatic patients : Use of CAM in Turkish asthma patients
Yasemin Tokem, Zeynep Ayfer Aytemur, Yasemin Yildirim, Cicek Fadiloglu
Journal of Clinical Nursing. 2011; : no
[VIEW] | [DOI]
27 CARD15 and TLR4 polymorphisms in atopic bronchial asthma
O. E. Voronko, E. V. Dmitrieva-Zdorova, E. A. Latysheva, M. G. Aksenova, G. I. Storozhakov, N. V. Bodoev, A. I. Archakov
Molecular Biology. 2011; 45(5): 766
[VIEW] | [DOI]
28 Association of interleukin-13 gene polymorphisms with atopic bronchial asthma
E. V. Dmitrieva-Zdorova, O. E. Voronko, M. G. Aksenova, N. V. Bodoev
Russian Journal of Genetics. 2010; 46(1): 99-104
[Pubmed] | [DOI]
29 Asthme et tuberculose : association bénéfique ou maléfique ?
L. Fekih,L. Boussoffara,M. Jemaa,S. Fenniche,H. Hassene,D. Belhabib,M.L. Megdiche
Revue des Maladies Respiratoires. 2010; 27(7): 679
[Pubmed] | [DOI]
O E Voronko, E V Dmitrieva-Zdorova, E A Latysheva, M G Aksenova, G I Storozhakov, N V Bodoev
Russian Journal of Allergy. 2010; 7(6): 20
[Pubmed] | [DOI]
31 Tuberculosis in patients with asthma | [Asthme et tuberculose: Association bénéfique ou maléfique?]
Fekih, L., Boussoffara, L., Jemaa, M., Fenniche, S., Hassene, H., Belhabib, D., Megdiche, M.L.
Revue des Maladies Respiratoires. 2010; 27(7): 679-684
32 Tuberculosis in patients with asthma [Asthme et tuberculose: Association bénéfique ou maléfique?]
Fekih, L. and Boussoffara, L. and Jemaa, M. and Fenniche, S. and Hassene, H. and Belhabib, D. and Megdiche, M.L.
Revue des Maladies Respiratoires. 2010; 27(7): 679-684
33 New FDA safety warnings for LABAs: A call for asthma guidelines revisit for solo beta agonist
Koshak, E.A.
Annals of Thoracic Medicine. 2010; 5(2): 65-66
34 New FDA safety warnings for LABAs: A call for asthma guidelines revisit for solo beta agonist
Koshak, E.A.
Annals of Thoracic Medicine. 2010; 5(2): 65-66
35 The Saudi initiative for asthma
Al-Moamary, M., Al-Hajjaj, M., Idrees, M., Zeitouni, M., Alanezi, M., Al-Jahdal, H., Al Dabbagh, M.
Annals of Thoracic Medicine. 2009; 4(4): 216-233
36 C-reactive protein monitoring in children with acute asthma | [Praćenje koncentracije C-reaktivnog proteina u djece s astmom]
Raos, M., Dodig, S.
Paediatria Croatica. 2007; 51(3): 105-109


Print this article  Email this article
   Next article
   Previous article 
   Table of Contents
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Article in PDF (94 KB)
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
* Registration required (free)  

    Article Tables

 Article Access Statistics
    PDF Downloaded2019    
    Comments [Add]    
    Cited by others 36    

Recommend this journal